Similar Articles
721 Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis
722 Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review
723 Liver transplantation for hepatocellular carcinoma: Where do we stand?
724 Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma
725 Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
726 Mechanisms of hepatocellular carcinoma progression
727 Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma
728 Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review
729 ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma
730 Role and mechanism of circ-PRKCI in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA